Cytochrome P450 monooxygenase; part of the gene cluster that mediates the biosynthesis of paxilline, a mycotoxin that acts as an inhibitor of mammalian maxi-K channels (PubMed:11169115, PubMed:23949005). PaxG, the geranylgeranyl diphosphate (GGPP) synthase is proposed to catalyze the first step in paxilline biosynthesis (PubMed:23949005). Condensation of indole-3-glycerol phosphate with GGPP by paxC then forms 3-geranylgeranylindole (3-GGI), followed by epoxidation and cyclization of this intermediate (by paxM and paxB) to form paspaline (PubMed:23949005). Paspaline is subsequently converted to 13-desoxypaxilline by paxP, the latter being then converted to paxilline by paxQ (PubMed:23949005, PubMed:17428785). Finally paxilline can be mono- and di-prenylated by paxD (PubMed:23949005). PaxQ can also utilized beta-paxitriol and alpha-PC-M6 as substrates converting them to alpha-paxitriol (PubMed:17428785). Secondary metabolite biosynthesis. Impairs the production of paxilline (PubMed:23949005). Leads to the accumulation of the 13-desoxypaxillin intermediate (PubMed:12884010). Belongs to the cytochrome P450 family.